Uveal malignant melanoma (UMM) is a rare malignant adult neoplasm (incidence: 1/1 000 000), but it is the most common intraocular primary malignancy. UMM can occur in a familial setting (reviewed in Canning and Hungerford, 1988) . Large studies have statistically demonstrated an excess of UMM risk in relatives of UMM patients (Singh et al, 1996b) and it is now assumed that at least 0.6% of all uveal melanoma cases are familial (Singh et al, 1996a) . Moreover, observation of large pedigrees has shown that transmission was autosomal dominant with incomplete penetrance (Lynch et al, 1968) , and that bilateral uveal melanoma occurred more frequently than expected (Singh et al, 1996e) . Numerous clinical and biological data suggest common hereditary factors for UMM and cutaneous melanoma (CMM). UMM may occur in familial CMM probands (Newton Bishop et al, 1994; Van Hees et al, 1998) . CMM may be present in first-degree relatives of UMM patients, often in association with dysplastic naevus syndrome (DNS) (Van Hees et al, 1998) . Co-existence of UMM and CMM in a same individual occur in up to 2% of UMM patients (Bataille et al, 1993; Van Hees et al, 1998) . Finally, uveal and cutaneous melanocytes share a common embryology, originating in the neural crest. Both cells migrate to their respective site during embryological development, and may give rise to naevi and in some instances, to melanomas.
Some other clinical conditions seem to predispose to UMM: ocular melanocytosis, neurofibromatosis type I, and Li-Fraumeni syndrome (Singh et al, 1996e) . At a genetic level, BRCA2 germline mutations may be associated with an increased risk of UMM (Easton et al, 1997; Sinilnikova et al, 1999) .
Inactivating germline mutations of the p16 INK4A gene have been found to segregate with the disease in 15-50% of CMM families (familial atypical mole and melanoma syndrome (FAMMM) (reviewed in Dracopoli and Fountain, 1996) . The INK4A-ARF locus localized at 9p21 encodes two alternative reading frame proteins, P16
INK4A (exons 1α, 2 and 3) and P14 ARF (exons 1β, 2 and 3), both involved in the negative control of cell proliferation. P16
INK4A produces a G1 cell cycle arrest by inhibiting phosphorylation of the retinoblastoma protein by the cyclin-dependent kinases cdk4 and cdk6 (Serrano et al, 1993) . P14
ARF is a structurally different protein, which has been recently shown to act both at G1/S and G2/M phases, in a p53-dependent manner. This is done via binding and inhibition of the protein MDM2, which itself promotes P53 degradation (Stott et al, 1998) . In addition, its murine homologue, P19 ARF , can directly associate with P53 (Kamijo et al, 1998 ARF or CDK4 genes might contribute to some cases of familial UMM, or to some cases of UMM associated with another melanoma. Out of 155 patients treated at the Institut Curie for UMM between 1994 and 1997, and interviewed about their personal and familial history of melanoma, we identified seven patients with a relative affected with UMM (n = 6) or CMM (n = 1), and two patients who have had, in addition to UMM, a personal history of second melanoma, UMM (n = 1), or CMM (n = 1). We screened by polymerase chain reaction single-strand conformation polymorphism the entire coding sequence of the INK4A-ARF locus (exon 1α from p16 A second melanoma-susceptibility gene, CDK4, was also recently characterized. Two different mutations, both occurring at codon 24 in exon 2 of the gene, were identified in three families, two American and one French (Zuo et al, 1996 , Soufir et al, 1998 . These mutations were shown to segregate in these CMM families and to prevent P16 INK4A binding (Zuo et al, 1996) . Several arguments support that these two genes may play a role in predisposition to UMM. First, UMM cases were present in melanoma families that have been linked to the 9p21 locus (Cannon-Albright et al, 1992) . Second, somatic deletions, loss of heterozygosity of 9p21 genetic markers or 5′CpG island methylation of p16
INK4A have been detected in UMM cell lines and primary sporadic UMM (Ohta et al, 1994; Speicher et al, 1994; Merbs et al, 1999) . Third, a loss of P16 INK4A -cdk4 proteins interaction was observed in UMM cell lines (Mouriaux et al., 1998) . This led us to search for germline mutations in the entire coding sequence of the INK4A-ARF locus (exon 1α, exon 1β, exon 2 and 3) and CDK4 (exons 2, 5 and 8) in individuals either with a familial history of UMM or with a personal history of melanoma, in addition to UMM.
PATIENTS AND METHODS

Families and patients selection
One hundred and fifty-five individuals (56% female, 44% male) affected with uveal melanoma and followed at the Institut Curie between January 1994 and September 1997 were interviewed about their personal and familial history of melanoma. Patients with at least an uveal or cutaneous melanoma in a first-to thirddegree relative, or with a personal history of second uveal or cutaneous melanoma were proposed for genetic interview. Further information on family members was therefore collected, including age at diagnoses, site of melanoma tumours and occurrence of other malignancies in affected family members. Diagnosis were based on ocular fundus examination, ultrasound and angiography, and cases treated by enucleation were confirmed by histopathology. Clinical examination of the skin in index cases looked for a dysplastic naevus syndrome (defined by more than 50 naevi, with at least one atypical mole). A blood sample was obtained by venipuncture, with their informed consent.
Molecular analysis
Genomic DNA was prepared from peripheral blood mononuclear cells isolated by centrifugation through a Ficoll gradient. Each of the four exons of the INK4A-ARF locus and the intron-exon junctions were analysed by polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP). Primer sequences for the exons 1α, 2, and 3 of the INK4A-ARF locus were described in Soufir et al (1998) . Exon 1β was analysed through two overlapping PCR products generated by using the following primers: p19F1 5′-TCAGGGAAGGGCGGGTGCG-3′, P19R1 5′-GCC-GCGGGATGTGAACCA-3′ (PCR product: 245 bp), p19F2 5′-GCCGCGAGTGAGGGTTTT-3′, p19R2 5′-CACCGCGGTTAT-CTCCTC-3′ (PCR product 257 bp).
Functional and mutational studies of CDK4 gene have focused on the regions involved in P16
INK4A binding, particularly in domains encompassing the first 58 N-terminal aminoacids or the C-terminal region (Zuo et al, 1996; Coleman et al, 1997; Byeon et al, 1998 ) and corresponding to exons 2, 5 and 8 of the gene. These three exons were amplified using flanking intronic primers: (i) exon 2 CDK4F2 5′-AGCGACTTTTGGTGATAGGAGT-3′, CDK4R2 5′-GGCTGTCTTTTCCCTTTACTC-3′ (PCR product: 322 bp), (ii) exon 5, CDK4F5 5′-AGAGTGATTGCCCGTAGC-3′, CDK4R5 5′-GCAAGGTATGGATGTGGT-3′ (PCR product: 296 bp), and (iii) exon 8, CDK4F8 5′-GCTCATCCCAGGTATTGT-3′, CDK4R8 5′-TTGCCCTCTCAGTGTCCA-3′ (PCR product: 234 bp). Total PCR reactions volume was 20 µl including 50-100 ng of genomic DNA template, 30 pmol of each primer, 0.5 UI of Taq polymerase (Gibco-BRL) and 0.1 µl of α33P-dCTP (Amersham). Final magnesium chloride (MgCl 2 ) concentration was 1.5 mM for all PCR reactions. All reactions were supplemented with 10% dimethyl sulphoxide (DMSO) for optimal PCR amplification. PCR was processed with an annealing temperature of 60°C for the four exons of the INK4A-ARF locus, and 55°C for the three studied exons of CDK4. For SSCP, all PCR products were migrated on two 0.1 × TBE/Hydrolink MDE gels (FMC Bioproducts), with 8% glycerol at room temperature (RT) and without glycerol at +4°C. Gels were run at 8W, either 14 h at RT or 12 h at 4°C, dried and exposed for autoradiography. Sample containing p16
INK4A exon 3 variant migrating band was sequenced on both strands by automated sequencing using the primers mentioned above. Products from 50-µl PCR reactions were purified using a Microcon 100 (Amicon) and sequenced using dyelabelled terminator on an automated sequencer 373 (Applied Biosystem) according to the manufacturer's instructions.
RESULTS
Clinical data
Among the 155 patients with UMM, nine patients (5.8%) were selected for genetic analysis (Table 1) . Nineteen out of 20 melanoma cases (95%) could be confirmed from medical records. Seven patients had one relative affected with UMM (families 1-4, 6 and 7) or CMM (family 5). In three families, the affected cases were first-degree related (families 1-3); in two, they were seconddegree related (families 4 and 5), and in the last two, they were third-degree related (families 6 and 7). In the families 3 and 7, the affected relative had, in addition to UMM, a CMM. Besides these seven familial cases, two patients reported a history of second primary melanoma (families 8 and 9). One had a bilateral UMM (family 8) and the other, a CMM (family 9). Median age at diagnosis was 56 years old (41-80), and sex ratio, three women for one man. Only one proband (family 9) had a typical dysplastic naevus syndrome, with numerous atypical moles. In three families, different malignancies were also present, all confirmed from medical records (Table 1) . In family 3, a prolactin adenoma was observed in both affected relatives, in addition to UMM. In family 5, a bilateral breast cancer was present in the index case, as well as a colon cancer and an ovary cancer in the affected relative. In family 9, the index case had in addition a basal cell carcinoma.
Molecular analysis
Each proband was screened by PCR-SSCP for germline mutation of the INK4A-ARF locus. No abnormal pattern was detected either in exon 1α or in exon 2. One abnormal migrating pattern was observed in exon 3 in one out of nine samples (family 8), corresponding to a previously reported nucleotide variant C to G at position 500 (nucleotide numbering beginning at the first ATG site), located in the p16 INK4A cDNA 3′ untranslated region (Chaubert et al, 1996) . In addition, no sequence variant in exon 1β of the p14 ARF gene was detected in any of the samples, therefore suggesting that germline mutations in the INK4A-ARF locus are not a common event in genetic predisposition to UMM. SSCP analysis of the functional domains of the CDK4 gene did not reveal any SSCP variants in the nine samples.
DISCUSSION
We have investigated nine white French families that had a highly suspected UMM predisposition, owing to a personal or familial history of multiple melanomas. Approximately 1% of patients affected with UMM report a first-to third-degree relative affected with the same disease (Singh et al, 1996a) . The higher frequency of familial cases observed in our study (3.9%), as compared with previous reports, may reflect (i) sampling variation, or (ii) a slight bias towards the ascertainment of familial cases due to the availability of genetic counselling consultation at the Institut Curie. Nevertheless, our data confirm the association between UMM and CMM, either in relatives of UMM cases, or in the same individuals (families 3, 5, 7 and 9) as previously reported (Bataille et al, 1993) .
We did not detect any mutation in the coding sequence of either the INK4A-ARF locus or CDK4 gene in the nine families studied. We cannot rule out misdetection of mutations by SSCP, but this seems unlikely, as we recently reported one of the highest rates of p16 INK4A germline mutation in CMM families, using the same technical approaches (Soufir et al, 1998) . Our data enhance results of two previous studies: Wang et al did not find any pathogenic mutation in 13 UMM patients with a family history of melanoma, either uveal (n = 6), or cutaneous (n = 7) (Wang et al, 1996) ; Singh et al did not detect either any mutation in eight families with two members affected with UMM (Singh et al 1996c) . All 30 UMM families studied worldwide up to now have in common an absence of mutation in p16
INK4A
, therefore supporting the rare involvement of this gene in genetic predisposition to UMM.
A single nucleotide substitution (G to C) was detected in the 3′ untranslated region of exon 3 of p16
, in one out of nine patients (11%), affected with bilateral UMM (family 8). This nucleotide variant has been previously assessed as being a silent polymorphism with a maximum frequency of 25% in a European white population (Chaubert et al, 1996) , and of 29% in a set of sporadic CMM (Kumar et al, 1998) . However, more recently, Aitken et al reported that in CMM prone-families from Queensland, this polymorphism might be overrepresented as compared to a healthy population and could therefore have a deleterious effect (Aitken et al, 1999) . This seems unlikely in UMM given the low frequency of this variant in our series of nine patients.
Liu et al recently reported a germ-line transversion G¡T at base -34 of p16 INK4A (in the 5′ UTR), creating an aberrant initiation codon, in two CMM families (Liu et al, 1999) . In our study, we detected no mutation up to 104 bp upstream of the first translation site. Nonetheless, we cannot rule out mutations in the promoter or other regulatory region of p16
. We did not detect any germline mutation in exon 1β from p14 ARF in our set of families, which supports that this gene is not involved in predisposition to UMM. Yet, it should be pointed out that large hemizygous deletions of the INK4A-ARF locus may have escaped our mutation detection strategy. However, such genomic rearrangements seem rather to predispose to melanoma-astrocytoma syndrome (Bahuau et al, 1998) . We did not find any germline mutation in CDK4 gene. Thus, despite the fact that our series is small and CDK4 is less frequently involved in familial CMM than p16
, CDK4 gene does not seem to play a major role in genetic predisposition to UMM. This conclusion is consistent with previous data reporting the absence of somatic mutation of this gene in 30 primary uveal melanomas (Tsao et al, 1998) . However, to rule out definitively CDK4 as a UMM predisposing gene, further studies should be performed on larger family sets.
Genes other than p16
, p14 ARF and CDK4 might be involved in predisposition to UMM. First, involvement of another gene localized within the 9p21 locus is supported by (i) the occurrence of somatic deletions of 9p21 markers in up to 30% of UMM tumours (Otah et al, 1994) , (ii) the presence of homozygous somatic deletions sparing the INK4A-ARF locus in CMM tumours (Puig et al, 1995) , and (iii) the absence of p16 INK4A germline mutation in cutaneous melanoma kindreds linked to 9p21 locus (Kamb et al, 1994; Liu et al, 1997) . Second, a third melanoma susceptibility locus at 1p36 was initially characterized for the combined melanoma/dysplastic naevus trait (Bale et al, 1989; Goldstein et al, 1993) . As UMM and CMM may be genetically related via the sporadic DNS or the FAMMM syndrome (Bataille et al, 1993; Singh et al, 1996c; Van Hees et al, 1998) , this locus might be involved in genetic predisposition to UMM. Third, BRCA2 germline mutations might account for some UMM cases associated with a personal history of breast cancer (Sinilnikova et al, 1999) . However, in family 7, no germline BRCA2 mutation was detected despite the strong suggestion for the involvement of this gene (Table 1) (Sinilnikova et al, 1999) .
Finally, loss of heterozygosity and cytogenetic studies have suggested that tumour suppressor genes on chromosomes 2, 3 and 6, as well as an oncogene on chromosome 8q, could be involved in the tumorigenic process of uveal tumours .
In conclusion, our results suggest that germline mutations of p16
, p14 ARF and CDK4 genes are not frequently observed in genetic predisposition to UMM. This confirms genetic heterogeneity, therefore supporting the existence of additional melanoma susceptibility genes.
